10 20 30 40 50 60 70 80 1N07 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER TRANSFERASE 11-OCT-02 1N07
TITLE CRYSTAL STRUCTURE OF SCHIZOSACCHAROMYCES POMBE RIBOFLAVIN TITLE 2 KINASE REVEALS A NOVEL ATP AND RIBOFLAVIN BINDING FOLD
COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE RIBOFLAVIN KINASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 2.7.1.26; COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SCHIZOSACCHAROMYCES POMBE; SOURCE 3 ORGANISM_COMMON: FISSION YEAST; SOURCE 4 ORGANISM_TAXID: 4896; SOURCE 5 GENE: SPCC18.16C; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PNCO
KEYWDS KINASE, PHOSPHORYL TRANSFERASES, FLAVIN COFACTORS, METAL KEYWDS 2 BINDING
EXPDTA X-RAY DIFFRACTION
AUTHOR S.BAUER,K.KEMTER,A.BACHER,R.HUBER,M.FISCHER,S.STEINBACHER
REVDAT 2 24-FEB-09 1N07 1 VERSN REVDAT 1 25-FEB-03 1N07 0
JRNL AUTH S.BAUER,K.KEMTER,A.BACHER,R.HUBER,M.FISCHER, JRNL AUTH 2 S.STEINBACHER JRNL TITL CRYSTAL STRUCTURE OF SCHIZOSACCHAROMYCES POMBE JRNL TITL 2 RIBOFLAVIN KINASE REVEALS A NOVEL ATP AND JRNL TITL 3 RIBOFLAVIN BINDING FOLD JRNL REF J.MOL.BIOL. V. 326 1463 2003 JRNL REFN ISSN 0022-2836 JRNL PMID 12595258 JRNL DOI 10.1016/S0022-2836(03)00059-7
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 2.45 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 11694 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.285 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 602 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2531 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 116 REMARK 3 SOLVENT ATOMS : 82 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.26 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1N07 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-OCT-02. REMARK 100 THE RCSB ID CODE IS RCSB017355.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JAN-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.542 REMARK 200 MONOCHROMATOR : OSMIC REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11694 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.450 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 200 DATA REDUNDANCY : 2.200 REMARK 200 R MERGE (I) : 0.04100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.54 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.24200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 1N05 REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.27 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, PH 8.0, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 293K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 THR A 2 REMARK 465 VAL A 3 REMARK 465 ASN A 4 REMARK 465 LEU A 5 REMARK 465 GLU A 6 REMARK 465 GLU A 7 REMARK 465 LYS A 8 REMARK 465 VAL A 163 REMARK 465 MET B 1 REMARK 465 THR B 2 REMARK 465 VAL B 3 REMARK 465 ASN B 4 REMARK 465 LEU B 5 REMARK 465 GLU B 6 REMARK 465 GLU B 7 REMARK 465 VAL B 163
REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 91 CB CG CD CE NZ REMARK 480 LYS B 89 CB CG CD CE NZ
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 91 108.21 -50.77 REMARK 500 ASP B 51 3.75 -57.29 REMARK 500 LYS B 91 85.94 84.77 REMARK 500 PHE B 107 36.85 -149.30 REMARK 500 GLU B 109 -1.14 63.55 REMARK 500 ASN B 125 -135.23 -73.48 REMARK 500 TYR B 126 134.58 -174.50 REMARK 500 ALA B 127 47.16 -144.55 REMARK 500 PHE B 161 -71.27 -80.07 REMARK 500 REMARK 500 REMARK: NULL
REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 FMN A 165
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP A 164 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP B 201 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMN A 165 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMN B 202
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1N05 RELATED DB: PDB REMARK 900 RIBOFLAVIN KINASE, LIGAND FREE REMARK 900 RELATED ID: 1N06 RELATED DB: PDB REMARK 900 RIBOFLAVIN KINASE, ADP-COMPLEX REMARK 900 RELATED ID: 1N08 RELATED DB: PDB
DBREF 1N07 A 1 163 UNP O74866 RIFK_SCHPO 1 163 DBREF 1N07 B 1 163 UNP O74866 RIFK_SCHPO 1 163
SEQRES 1 A 163 MET THR VAL ASN LEU GLU GLU LYS ARG PRO GLU ILE VAL SEQRES 2 A 163 GLY PRO GLU LYS VAL GLN SER PRO TYR PRO ILE ARG PHE SEQRES 3 A 163 GLU GLY LYS VAL VAL HIS GLY PHE GLY ARG GLY SER LYS SEQRES 4 A 163 GLU LEU GLY ILE PRO THR ALA ASN ILE SER GLU ASP ALA SEQRES 5 A 163 ILE GLN GLU LEU LEU ARG TYR ARG ASP SER GLY VAL TYR SEQRES 6 A 163 PHE GLY TYR ALA MET VAL GLN LYS ARG VAL PHE PRO MET SEQRES 7 A 163 VAL MET SER VAL GLY TRP ASN PRO TYR TYR LYS ASN LYS SEQRES 8 A 163 LEU ARG SER ALA GLU VAL HIS LEU ILE GLU ARG GLN GLY SEQRES 9 A 163 GLU ASP PHE TYR GLU GLU ILE MET ARG VAL ILE VAL LEU SEQRES 10 A 163 GLY TYR ILE ARG PRO GLU LEU ASN TYR ALA GLY LEU ASP SEQRES 11 A 163 LYS LEU ILE GLU ASP ILE HIS THR ASP ILE ARG VAL ALA SEQRES 12 A 163 LEU ASN SER MET ASP ARG PRO SER TYR SER SER TYR LYS SEQRES 13 A 163 LYS ASP PRO PHE PHE LYS VAL SEQRES 1 B 163 MET THR VAL ASN LEU GLU GLU LYS ARG PRO GLU ILE VAL SEQRES 2 B 163 GLY PRO GLU LYS VAL GLN SER PRO TYR PRO ILE ARG PHE SEQRES 3 B 163 GLU GLY LYS VAL VAL HIS GLY PHE GLY ARG GLY SER LYS SEQRES 4 B 163 GLU LEU GLY ILE PRO THR ALA ASN ILE SER GLU ASP ALA SEQRES 5 B 163 ILE GLN GLU LEU LEU ARG TYR ARG ASP SER GLY VAL TYR SEQRES 6 B 163 PHE GLY TYR ALA MET VAL GLN LYS ARG VAL PHE PRO MET SEQRES 7 B 163 VAL MET SER VAL GLY TRP ASN PRO TYR TYR LYS ASN LYS SEQRES 8 B 163 LEU ARG SER ALA GLU VAL HIS LEU ILE GLU ARG GLN GLY SEQRES 9 B 163 GLU ASP PHE TYR GLU GLU ILE MET ARG VAL ILE VAL LEU SEQRES 10 B 163 GLY TYR ILE ARG PRO GLU LEU ASN TYR ALA GLY LEU ASP SEQRES 11 B 163 LYS LEU ILE GLU ASP ILE HIS THR ASP ILE ARG VAL ALA SEQRES 12 B 163 LEU ASN SER MET ASP ARG PRO SER TYR SER SER TYR LYS SEQRES 13 B 163 LYS ASP PRO PHE PHE LYS VAL
HET ADP A 164 27 HET ADP B 201 27 HET FMN A 165 31 HET FMN B 202 31
HETNAM ADP ADENOSINE-5'-DIPHOSPHATE HETNAM FMN FLAVIN MONONUCLEOTIDE
HETSYN FMN RIBOFLAVIN MONOPHOSPHATE
FORMUL 3 ADP 2(C10 H15 N5 O10 P2) FORMUL 5 FMN 2(C17 H21 N4 O9 P) FORMUL 7 HOH *82(H2 O)
HELIX 1 1 GLU A 50 ILE A 53 5 4 HELIX 2 2 GLY A 128 ASP A 148 1 21 HELIX 3 3 ARG A 149 SER A 154 1 6 HELIX 4 4 TYR A 155 LYS A 162 5 8 HELIX 5 5 GLU B 50 ILE B 53 5 4 HELIX 6 6 GLY B 128 MET B 147 1 20 HELIX 7 7 ARG B 149 SER B 154 1 6 HELIX 8 8 TYR B 155 ASP B 158 5 4
SHEET 1 A 7 ILE A 24 VAL A 31 0 SHEET 2 A 7 ALA A 46 ILE A 48 -1 O ASN A 47 N VAL A 31 SHEET 3 A 7 ARG A 93 LEU A 99 -1 O VAL A 97 N ALA A 46 SHEET 4 A 7 ARG A 74 TRP A 84 -1 N GLY A 83 O SER A 94 SHEET 5 A 7 GLY A 63 VAL A 71 -1 N GLY A 63 O VAL A 82 SHEET 6 A 7 ILE A 111 ARG A 121 -1 O ARG A 113 N MET A 70 SHEET 7 A 7 ILE A 24 VAL A 31 -1 N GLY A 28 O MET A 112 SHEET 1 B 7 ILE B 24 VAL B 31 0 SHEET 2 B 7 ALA B 46 ILE B 48 -1 O ASN B 47 N VAL B 31 SHEET 3 B 7 ARG B 93 LEU B 99 -1 O VAL B 97 N ALA B 46 SHEET 4 B 7 VAL B 75 TRP B 84 -1 N GLY B 83 O SER B 94 SHEET 5 B 7 GLY B 63 MET B 70 -1 N GLY B 67 O MET B 78 SHEET 6 B 7 ILE B 111 ARG B 121 -1 O ARG B 113 N MET B 70 SHEET 7 B 7 ILE B 24 VAL B 31 -1 N GLY B 28 O MET B 112
CISPEP 1 SER A 20 PRO A 21 0 0.42 CISPEP 2 TYR A 22 PRO A 23 0 0.32 CISPEP 3 SER B 20 PRO B 21 0 1.05 CISPEP 4 TYR B 22 PRO B 23 0 0.21
SITE 1 AC1 17 VAL A 30 HIS A 32 GLY A 33 ARG A 36 SITE 2 AC1 17 GLY A 37 SER A 38 LYS A 39 PRO A 44 SITE 3 AC1 17 THR A 45 VAL A 97 HIS A 98 LEU A 99 SITE 4 AC1 17 ASP A 106 PHE A 107 TYR A 108 HOH A 170 SITE 5 AC1 17 TYR B 88 SITE 1 AC2 19 TYR A 88 GLY B 33 GLY B 35 ARG B 36 SITE 2 AC2 19 GLY B 37 SER B 38 LYS B 39 PRO B 44 SITE 3 AC2 19 THR B 45 VAL B 97 HIS B 98 LEU B 99 SITE 4 AC2 19 ARG B 102 ASP B 106 PHE B 107 TYR B 108 SITE 5 AC2 19 HOH B 208 HOH B 220 HOH B 241 SITE 1 AC3 8 VAL A 64 SER A 81 ARG A 121 GLU A 123 SITE 2 AC3 8 LEU A 124 TYR A 126 LEU A 132 ASP A 139 SITE 1 AC4 11 ARG B 36 THR B 45 ASN B 47 VAL B 64 SITE 2 AC4 11 SER B 81 GLU B 96 ARG B 121 GLU B 123 SITE 3 AC4 11 LEU B 124 ASN B 125 LEU B 132
CRYST1 38.807 45.767 51.895 90.69 111.03 97.31 P 1 2
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.025769 0.003306 0.010133 0.00000
SCALE2 0.000000 0.022029 0.001376 0.00000
SCALE3 0.000000 0.000000 0.020685 0.00000